SG11201806432PA - Methods for assessing risk of developing colorectal cancer - Google Patents

Methods for assessing risk of developing colorectal cancer

Info

Publication number
SG11201806432PA
SG11201806432PA SG11201806432PA SG11201806432PA SG11201806432PA SG 11201806432P A SG11201806432P A SG 11201806432PA SG 11201806432P A SG11201806432P A SG 11201806432PA SG 11201806432P A SG11201806432P A SG 11201806432PA SG 11201806432P A SG11201806432P A SG 11201806432PA
Authority
SG
Singapore
Prior art keywords
international
victoria
methods
parkville
melbourne
Prior art date
Application number
SG11201806432PA
Other languages
English (en)
Inventor
Mark Jenkins
Daniel Buchanan
John L Hopper
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016900254A external-priority patent/AU2016900254A0/en
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of SG11201806432PA publication Critical patent/SG11201806432PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
SG11201806432PA 2016-01-28 2017-01-27 Methods for assessing risk of developing colorectal cancer SG11201806432PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2016900254A AU2016900254A0 (en) 2016-01-28 Methods for assessing risk of developing colorectal cancer
AU2016903246A AU2016903246A0 (en) 2016-08-16 Methods for assessing risk of developing colorectal cancer
PCT/AU2017/050066 WO2017127893A1 (en) 2016-01-28 2017-01-27 Methods for assessing risk of developing colorectal cancer

Publications (1)

Publication Number Publication Date
SG11201806432PA true SG11201806432PA (en) 2018-08-30

Family

ID=59396853

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806432PA SG11201806432PA (en) 2016-01-28 2017-01-27 Methods for assessing risk of developing colorectal cancer

Country Status (11)

Country Link
US (1) US11773448B2 (he)
EP (1) EP3408412B1 (he)
JP (2) JP7126704B2 (he)
KR (1) KR20180123480A (he)
CN (1) CN109072308A (he)
AU (1) AU2017212152B2 (he)
CA (1) CA3012783A1 (he)
IL (1) IL260777B (he)
MX (1) MX2018009254A (he)
SG (1) SG11201806432PA (he)
WO (1) WO2017127893A1 (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7101143B2 (ja) * 2019-04-23 2022-07-14 ジェネシスヘルスケア株式会社 大腸がんのリスクを判定する方法
CN111057767A (zh) * 2020-01-19 2020-04-24 北京市第一中西医结合医院 一种中国人胃肠道肿瘤风险相关的位于mlh1基因的snp位点及其应用
CN111739642A (zh) * 2020-06-23 2020-10-02 杭州和壹医学检验所有限公司 一种结直肠癌风险预测方法、系统、计算机设备及可读存储介质
CN112029852B (zh) * 2020-09-24 2023-12-05 吉林大学 ONFH易感相关TNF-α、GREM1、TGF-β、CR2基因SNP检测物质
CN114672556A (zh) * 2020-12-25 2022-06-28 上海善准生物科技有限公司 结直肠癌分子分型及生存风险基因群及诊断产品和应用
CN114334142A (zh) * 2021-07-02 2022-04-12 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种用于结直肠癌发病风险预测的snp位点组合、发病风险预测模型及系统
CN115786501B (zh) * 2022-07-02 2023-06-16 武汉大学 一种与结直肠癌早期筛查和辅助诊断相关的增强子功能位点及其应用
CN116949179A (zh) * 2023-07-04 2023-10-27 中国医学科学院北京协和医院 结直肠肿瘤多基因遗传风险评分系统、存储介质和电子设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147035A (en) 1978-05-10 1979-11-16 Minolta Camera Co Ltd Tessar type photographic lens placed behind aperture
US4240608A (en) 1979-11-02 1980-12-23 Acf Industries, Incorporated Controlled float seat arrangement for expanding gate valves
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
DK1179600T3 (da) 1996-06-04 2005-09-05 Univ Utah Res Found Overvågning af hybridisering under PCR
US6174170B1 (en) 1997-10-21 2001-01-16 Sony Corporation Display of text symbols associated with audio data reproducible from a recording disc
AU785425B2 (en) 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
US6898531B2 (en) 2001-09-05 2005-05-24 Perlegen Sciences, Inc. Algorithms for selection of primer pairs
WO2003021259A1 (en) 2001-09-05 2003-03-13 Perlegen Sciences, Inc. Selection of primer pairs
US20040023237A1 (en) 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US6897025B2 (en) 2002-01-07 2005-05-24 Perlegen Sciences, Inc. Genetic analysis systems and methods
US20050019787A1 (en) 2003-04-03 2005-01-27 Perlegen Sciences, Inc., A Delaware Corporation Apparatus and methods for analyzing and characterizing nucleic acid sequences
US20040241657A1 (en) 2003-05-28 2004-12-02 Perlegen Sciences, Inc. Liver related disease compositions and methods
US7127355B2 (en) 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
KR101206029B1 (ko) * 2005-04-01 2012-11-28 삼성전자주식회사 대장암 진단용 다중 snp, 그를 포함하는 마이크로어레이및 키트 및 그를 이용한 대장암 진단 방법
CA2721313A1 (en) * 2008-04-10 2009-10-15 Genenews Corporation Method and apparatus for determining a probability of colorectal cancer in a subject
CN102876791B (zh) * 2012-09-21 2015-09-02 湖北维达健基因技术有限公司 一种用于肛肠疾病患病风险评估基因芯片、制备方法及其试剂盒
WO2016061246A1 (en) 2014-10-14 2016-04-21 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with cancer risk
US10609708B1 (en) 2017-06-27 2020-03-31 Sprint Spectrum L.P. Use of TDD special subframe for transmission of small quantity of data

Also Published As

Publication number Publication date
MX2018009254A (es) 2019-05-06
JP2019510473A (ja) 2019-04-18
JP2022104934A (ja) 2022-07-12
US20190161802A1 (en) 2019-05-30
AU2017212152A1 (en) 2018-08-16
AU2017212152B2 (en) 2019-07-11
EP3408412A4 (en) 2020-01-15
WO2017127893A1 (en) 2017-08-03
CN109072308A (zh) 2018-12-21
EP3408412B1 (en) 2024-03-20
EP3408412A1 (en) 2018-12-05
US11773448B2 (en) 2023-10-03
IL260777B (he) 2022-09-01
IL260777A (he) 2018-09-20
KR20180123480A (ko) 2018-11-16
JP7126704B2 (ja) 2022-08-29
CA3012783A1 (en) 2017-08-03

Similar Documents

Publication Publication Date Title
SG11201806432PA (en) Methods for assessing risk of developing colorectal cancer
SG11201910019PA (en) Microorganisms and methods for producing cannabinoids and cannabinoid derivatives
SG11201908088RA (en) Antibodies against pd-l1
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201900138TA (en) Programmed death 1 ligand 1 (pd-l1) binding proteins and methods of use thereof
SG11201907753TA (en) Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereof
SG11201808797XA (en) T cell receptors
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201805906WA (en) Diagnostic and prognostic methods for cardiovascular diseases and events
SG11201908238SA (en) Anti-c5 antibodies and uses thereof
SG11201908847TA (en) Apparatuses, systems and methods for imaging flow cytometry
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201809374VA (en) Cd40l-fc fusion polypeptides and methods of use thereof
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201908743SA (en) Methods and compositions for modulation of immune cells
SG11201906778RA (en) Improved methods for assessing risk of developing breast cancer
SG11201901172QA (en) A method for manufacturing a fuel component
SG11201910195WA (en) Methods for trapping and barcoding discrete biological units in hydrogel
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201808992UA (en) Compositions and methods for the detection of host cell proteins
SG11201907208XA (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
SG11201808882QA (en) Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof
SG11201908091QA (en) Aqueous anti-pd-l1 antibody formulation
SG11201807478QA (en) Methods and compositions for increased double stranded rna production